APPLICATION
BLA761078
TYPE
BLA
ORIGINAL APPROVAL
2017-05-09
LATEST ACTION
2017-05-09
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
BAVENCIOPrescription
AVELUMAB 20MG/ML · INJECTABLE · INTRAVENOUS
Approval history
2017-05-09Type 9 - New indication submitted as distinct BLA, consolidated · Original · priority — Label ↗AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.